Cravath Wins M&A Atlas Award

Cravath won the “Healthcare Industries Deal of the Year” M&A Atlas Award for its work on Bristol-Myers Squibb’s $4.1 billion divestiture of its ConvaTec wound-therapeutics and ostomy unit to Nordic Capital and Avista Capital Partners. Global M&A Network, which produces M&A and alternative investing events for various international markets, presented the award at its Global M&A Major Markets Awards Gala and Ceremony held on January 21.

At the awards, Cravath was also recognized for its role in advising Weyerhaeuser Company in the $6 billion divestiture of its containerboard, packaging and recycling operations to International Paper Company, named the “Industrial Goods & Services Deal of the Year,” and its role in advising the Strategic Transactions Committee of the Board of TXU Corp. in its $45 billion acquisition by Kohlberg Kravis Roberts & Co. and Texas Pacific Group, named the “Consortium Deal of the Year.”